Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Sunesis Pharma Enters Into Licensing Agreement With Biogen Idec 11
Sunesis Pharma Enters Into Licensing Agreement With Millennium Pharma 13
Equity Offering 14
Sunesis Pharma to Raise up to USD15.5 Million in Private Placement of Shares 14
Sunesis Pharmaceuticals Raises USD20 Million in Public Offering of Shares 16
Sunesis Pharma Raises USD28 Million in Public Offering of Shares 18
Sunesis Pharma Raises USD17 Million in Public offering of Preferred Shares 20
Sunesis Pharma Raises USD9 Million in Public Offering of Shares 21
Sunesis Pharma Raises USD17 Million in Public Offering of Shares 23
Sunesis Pharma Prices Public offering of Shares for USD8 Million 25
Sunesis Pharma Completes Public Offering Of Common Stock And Warrants For US$43 Million 26
Asset Transactions 27
Royalty Pharma Completes Acquisition Of Royalty Agreement For Vosaroxin From Sunesis Pharma For US$25 Million 27
Sunesis Pharmaceuticals Inc – Key Competitors 29
Sunesis Pharmaceuticals Inc – Key Employees 30
Sunesis Pharmaceuticals Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Nov 05, 2018: Sunesis Pharmaceuticals reports third quarter 2018 financial results and recent highlights 32
Aug 07, 2018: Sunesis Pharmaceuticals reports second quarter 2018 financial results and recent highlights 33
May 08, 2018: Sunesis Pharmaceuticals Announces First Quarter 2018 Financial Results 35
Mar 08, 2018: Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights 36
Nov 02, 2017: Sunesis Pharmaceuticals Reports Third Quarter 2017 Financial Results and Recent Highlights 38
Jul 27, 2017: Sunesis Pharmaceuticals Reports Second Quarter 2017 Financial Results and Recent Highlights 40
May 08, 2017: Sunesis Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Highlights 42
Mar 09, 2017: Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial Results and Recent Highlights 44
Corporate Communications 46
Jul 09, 2018: Sunesis Pharmaceuticals Announces Senior Management Changes 46
Feb 07, 2018: Sunesis Pharmaceuticals Appoints Industry Veteran H. Ward Wolff to the Board of Directors 47
Dec 04, 2017: Sunesis Pharmaceuticals Announces Change in Leadership 48
Nov 30, 2017: Sunesis Pharmaceuticals Appoints William Quinn as CFO and Senior Vice President, Finance and Corporate Development 49
Legal and Regulatory 50
Jun 26, 2017: Sunesis Pharmaceuticals added to Russell Microcap Index 50
Product News 51
12/05/2017: Sunesis Pharmaceuticals to Provide Program Update for Non-Covalent BTK Inhibitor SNS-062 at Analyst & Investor Event during ASH 2017 51
07/18/2017: Sunesis Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 Study Evaluating Oral Non-Covalent BTK-inhibitor SNS-062 in Adults with Chronic Lymphocytic Leukemia and other B-Cell Malignancies 52
Product Approvals 53
May 01, 2017: Sunesis Pharmaceuticals Announces Withdrawal of European Marketing Authorization Application (MAA) for Vosaroxin as a Treatment for Relapsed/Refractory AML 53
Mar 22, 2017: Sunesis Pharmaceuticals Announces Submission of Responses to the EMA Day 180 List of Outstanding Issues for Marketing Authorization Application for Vosaroxin 54
Jan 23, 2017: Sunesis Pharmaceuticals Provides Update on SNS-062 55
Jan 23, 2017: Sunesis Pharmaceuticals Provides Update on Vosaroxin 56
Clinical Trials 57
Apr 03, 2017: Sunesis Pharmaceuticals Announces Presentation of The Ohio State University-Sponsored Preclinical Study of BTK Inhibitor SNS-062 at AACR Annual Meeting 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sunesis Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sunesis Pharma Enters Into Licensing Agreement With Biogen Idec 11
Sunesis Pharma Enters Into Licensing Agreement With Millennium Pharma 13
Sunesis Pharma to Raise up to USD15.5 Million in Private Placement of Shares 14
Sunesis Pharmaceuticals Raises USD20 Million in Public Offering of Shares 16
Sunesis Pharma Raises USD28 Million in Public Offering of Shares 18
Sunesis Pharma Raises USD17 Million in Public offering of Preferred Shares 20
Sunesis Pharma Raises USD9 Million in Public Offering of Shares 21
Sunesis Pharma Raises USD17 Million in Public Offering of Shares 23
Sunesis Pharma Prices Public offering of Shares for USD8 Million 25
Sunesis Pharma Completes Public Offering Of Common Stock And Warrants For US$43 Million 26
Royalty Pharma Completes Acquisition Of Royalty Agreement For Vosaroxin From Sunesis Pharma For US$25 Million 27
Sunesis Pharmaceuticals Inc, Key Competitors 29
Sunesis Pharmaceuticals Inc, Key Employees 30
Sunesis Pharmaceuticals Inc, Subsidiaries 31
List of Figures
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sunesis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9